MOBILE VIEW  | 

PLANTS-OXALATES

Classification   |    Detailed evidence-based information

Therapeutic Toxic Class

    A) Plants containing oxalates fall into 2 general categories:
    1) Those containing only SOLUBLE oxalates do not produce irritation but may be eaten in sufficient quantities to produce systemic oxalate toxicity (eg, hypocalcemia). Soluble forms include oxalic acid and sodium, potassium, and ammonium oxalate.
    2) Those containing INSOLUBLE calcium oxalate crystals can produce local pain and irritation and edema in the oral cavity, but rarely result in systemic effects.

Specific Substances

    A) SOLUBLE OXALATES
    1) Averrhoa carambola (star fruit)
    2) Boston ivy
    3) Garden sorrel (Rumex crispus)
    4) Halogeton glomeratus
    5) Oca (Oxalis tuberosa)
    6) Rhubarb
    7) Virginia creeper
    8) OXALATES, PLANTS
    9) OXALIC ACID, PLANTS
    10) PLANTS-OXALIC ACID
    INSOLUBLE OXALATES
    1) Agave species
    2) Alocasia odora
    3) Alocaisa cucullata
    4) Alocasia species (e.g., macrorrhiza)
    5) Arisaema triphyllum (Jack-in-the-pulpit)
    6) Achyrantes aspera L
    7) Caladium species
    8) Colocasia species (Elephants ear)
    9) Dieffenbachia species
    10) Monstera species
    11) Oxalis Cernua
    12) Oxalis Ecernua
    13) Oxalis corniculata
    14) Philodendron species
    15) Symptocarpus faetidus (Skunk cabbage)
    16) Xanthosoma species
    17) Zantedeschia aethiopica (Calla lily)
    18) INDIAN KALE (COMMON NAME OF XANTHOSOMA LINDENII)

Available Forms Sources

    A) SOURCES
    1) SUMMARY
    a) Members of this group include dieffenbachia, elephant's ear, skunk cabbage, rhubarb leaves, philodendron, carambola or star fruit, caladium, etc., and members of the arum group in general. All are members of the family Araceae (Arum), except a few members such as rhubarb and sorrel. Symptoms are more common following exposure to dieffenbachia than to philodendron (Mrvos et al, 1991).
    b) The amount of oxalates in these plants varies but seems to be highest during the rainy season (Franceschi & Horner, 1980).
    c) A foodborne illness outbreak associated with ingestion of plant material containing raphides (calcium oxalate crystals) has been reported. Ten office workers developed oral stinging and burning after eating a "Chinese braised vegetables entree" from the workplace cafeteria (Watson et al, 2005).
    2) OXALATES
    a) Oxalates typically cause GI irritation when ingested. Spathiphyllum (peace lily), an oxalate containing plant, is a leading cause of plant exposure in the US. Other common oxalate containing plants include philodendrons, dieffenbachia (dumb cane) and epipremnum areum (pothos) (Petersen, 2011).
    3) CATEGORIES
    a) Plants containing oxalates fall into 2 general categories:
    1) SOLUBLE SALTS: Those plants containing only SOLUBLE oxalates (eg, rhubarb (raw leaf blades), star fruit ) do not produce irritation but may be eaten in sufficient quantities to produce systemic oxalate toxicity (eg, hypocalcemia) (Nelson et al, 2007). Soluble forms include oxalic acid and sodium, potassium, and ammonium oxalate.
    2) INSOLUBLE SALTS: Those plants containing INSOLUBLE calcium oxalate crystals (eg, dieffenbachia, caladium) can produce local pain and irritation (ie, blistering) and edema in the oral cavity, but rarely result in systemic effects. Hoarseness, dysphonia and dysphagia may develop following oral exposure (Nelson et al, 2007).
    4) SELECT PLANTS
    a) RHUBARB: is a common plant that contains oxalates. The raw leaf blades are toxic if eaten in large quantities (Petersen, 2011; Nelson et al, 2007).

Life Support

    A) This overview assumes that basic life support measures have been instituted.

Clinical Effects

    0.2.1) SUMMARY OF EXPOSURE
    A) BACKGROUND: SPECIES: Members of this group include dieffenbachia, elephant's ear, skunk cabbage, rhubarb leaves, philodendron, Averrhoa carambola (star fruit), caladium, etc., and in general most members of the arum group. All are members of the family Araceae (Arum), except a few members such as rhubarb and sorrel. Local symptoms are more common following dieffenbachia exposure.
    B) TOXICOLOGY: Family: Araceae: Dieffenbachia, Elephant's Ear, Caladiums, Calla Palustris (Water Dragon): Toxin: Raphides of water-insoluble calcium oxalate and unverified proteinaceous toxins. Family Polygonaceae: Rhubarb: Toxin: Anthraquinone glycosides and soluble oxalates. Family: Oxalidaceae (ie, Averrhoa carambola [star fruit}): Toxin: an oxalate that can produce neurotoxicity.
    C) EPIDEMIOLOGY: In most cases, exposure is due to common household plants. Exposure is likely to occur in young patients; severe toxicity is unlikely to occur.
    D) WITH POISONING/EXPOSURE
    1) EXPOSURE: PLANT TOXICITY: Plants containing oxalates usually are divided into 2 general categories: INSOLUBLE SALTS: Plants containing large amounts of needle-like calcium oxalate are not generally ingested in large enough quantities to produce systemic intoxication. Symptoms, when they occur, are generally local, manifesting as oral injury. A painful burning sensation of the lips and mouth following ingestion, inflammatory response often occurs and hoarseness, dysphonia and dysphagia may develop. Large quantities, if ingested, may produce some of the symptoms of the soluble salt plants. SOLUBLE SALTS: Plants with sodium or potassium salts may occasionally be eaten in sufficient quantities to produce systemic intoxication. Absorption is more likely with these plants since little mouth pain occurs, unlike the plants with crystal needles. Onset of symptoms is generally 2 to 12 hours. Renal, myocardial, brain, and liver damage is possible, as is gastroenteritis (ie, nausea, vomiting, diarrhea and abdominal pain). Seizures and coma have been reported after ingestion of star fruit by patients with a history of renal impairment.
    0.2.3) VITAL SIGNS
    A) WITH POISONING/EXPOSURE
    1) HYPOTHERMIA: After the ingestion of 3 star fruits, a 60-year-old man with chronic renal failure developed hypothermia (temperature 30.4 degrees C). His temperature returned to normal after rewarming and two sessions of hemodialysis (Chen et al, 2005).
    0.2.4) HEENT
    A) WITH POISONING/EXPOSURE
    1) INSOLUBLE SALTS: Irritation of the oral mucosa, including the mouth, tongue and throat occur, but in less than 20% of patients who have an oral exposure.
    2) INSOLUBLE SALTS: Ocular exposure to expressed sap may cause immediate pain, lacrimation, photophobia, corneal abrasions, and deposition of calcium oxalate crystals on the corneal epithelium.
    0.2.6) RESPIRATORY
    A) WITH POISONING/EXPOSURE
    1) INSOLUBLE SALTS: Respiratory distress may occur if edema of the tongue and oropharynx is severe.
    2) SOLUBLE SALTS: Plants with sodium or potassium salts of oxalic acid, if eaten in sufficient quantities may produce systemic intoxication (Boston ivy, rhubarb leaves, Virginia creeper). Absorption is more likely with these plants since little oral irritation occurs.
    0.2.8) GASTROINTESTINAL
    A) WITH POISONING/EXPOSURE
    1) Adverse sequelae are uncommon following oral exposure to plants that contain insoluble calcium oxalate crystals. Rare reports described the development of edema, vesicles and lesions on the lips, tongue, esophagus and glottis.
    0.2.10) GENITOURINARY
    A) WITH POISONING/EXPOSURE
    1) SOLUBLE SALTS: Renal damage may be noted following ingestion of soluble oxalates. This complication is uncommon in humans and generally occurs in animals after the ingestion of a large quantity of plant material. The development of symptoms may require 24 to 48 hours before symptomatology begins.
    0.2.15) MUSCULOSKELETAL
    A) WITH POISONING/EXPOSURE
    1) SOLUBLE SALTS: Tetany and muscle cramps may occur following ingestion.

Laboratory Monitoring

    A) Routine laboratory studies are not indicated.
    B) For diagnostic purposes in patients with severe poisoning, examine the urine for calcium oxalate crystals. This should not be performed routinely. Monitor calcium and renal function (BUN, creatinine).

Treatment Overview

    0.4.2) ORAL/PARENTERAL EXPOSURE
    A) MANAGEMENT OF MILD TO MODERATE TOXICITY
    1) ARACEAE FAMILY: Following a minor or "taste" ingestion an acute onset of oral pain and irritation is possible following exposure. Rinse mouth immediately and remove any plant (eg, dieffenbachia, caladium, elephant's ear) debris. Offer ice chips or popsicles to children to help minimize pain. Oral analgesics may be necessary. Monitor for evidence of more severe symptoms (ie, severe pain, drooling, or difficulty swallowing). Antihistamines, inhaled beta agonists, corticosteroids may be necessary to treat laryngeal swelling or edema.
    B) MANAGEMENT OF SEVERE TOXICITY
    1) Monitor respiratory and neurologic status. ARACEAE FAMILY: Monitor respiratory effort; airway support may be need in patients that develop difficulty swallowing, drooling or evidence of glossitis or laryngeal edema following exposure to plant (eg, dieffenbachia, elephant's ear) material. Treat with aggressive airway management, antihistamines, epinephrine, and corticosteroids. STAR FRUIT: Hiccups are often an early finding of star fruit intoxication. Altered mental status and seizure activity have been reported in patients at risk (ie, chronic renal disease) following ingestion; treat with antiepileptics. Hemodialysis and hemoperfusion have been used with some success based on limited reports following significant renal injury.
    C) DECONTAMINATION
    1) INSOLUBLE SALTS: Remove all visible evidence of plant (eg, caladium, dieffenbachia, elephant's ear) debris from the oropharynx and administer milk or water to rinse out crystals and assist with oropharynx decontamination. Ice chips or popsicles can be used to reduce oral pain.
    2) SOLUBLE SALTS (star fruit, rhubarb): Dilute with small amounts of water. Plants with sodium or potassium salts may occasionally be eaten in sufficient quantity to produce systemic intoxication. Absorption is more likely with these plants since little mouth pain occurs, unlike the plants with crystal needles.
    3) Activated charcoal is not recommended. Gastric lavage is probably of NO value, since it may be difficult to retrieve large amounts of plant material via a gastric lavage tube.
    D) AIRWAY MANAGEMENT
    1) Airway support is unlikely to be necessary following a "taste" or mild exposure. However, difficulty swallowing, drooling and stridor have occurred following minor dieffenbachia plant exposure. Airway management may be necessary in patients who develop upper airway edema. Surgical airway (cricothyrotomy or tracheostomy) may be necessary in patients with severe upper airway edema.
    E) HYPERSENSITIVITY REACTION
    1) MILD/MODERATE: Antihistamines with or without inhaled beta agonists, corticosteroids or epinephrine. SEVERE: Oxygen, aggressive airway management, antihistamines, epinephrine, corticosteroids, ECG monitoring, and IV fluids.
    F) ENHANCED ELIMINATION
    1) HEMODIALYSIS: It has been utilized in cases of severe acute oxalate nephropathy induced by ingestion of soluble oxalates in star fruit. HEMOPERFUSION: It has been associated with neurologic improvement in patients with a history of chronic renal disease who develop coma after the ingestion of star fruit.
    G) PATIENT DISPOSITION
    1) HOME CRITERIA: Asymptomatic or mild oral pain/irritation in a child with a minor taste ingestion can be managed at home with a responsible adult. Any increase in pain or evidence of drooling requires immediate further evaluation.
    2) OBSERVATION CRITERIA: Any patient who develops drooling, difficulty swallowing or more than mild symptoms (ie, ongoing or severe pain) should be sent to a healthcare facility for evaluation and treatment. If symptoms resolve completely in the emergency department, the patient may be discharged to home following psychiatric clearance as needed.
    3) ADMISSION CRITERIA: Patients who present with severe symptoms (ie, significant drooling or laryngeal swelling, respiratory distress, seizure activity, renal impairment) should be admitted to an intensive care setting. Also, admit patients with persistent symptoms that have not responded to therapy.
    4) CONSULT CRITERIA: Consult a medical toxicologist or poison center if the diagnosis is unclear.
    H) PITFALLS
    1) Symptoms may be delayed (2 to 12 hours) in patients that ingest star fruit (or other soluble salts). Systemic absorption is also more likely with soluble salts.
    I) DIFFERENTIAL DIAGNOSIS
    1) Other plants or agents that may produce localized swelling or hypersensitivity reactions.
    0.4.4) EYE EXPOSURE
    A) DECONTAMINATION: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, the patient should be seen in a healthcare facility.
    0.4.5) DERMAL EXPOSURE
    A) OVERVIEW
    1) DECONTAMINATION: Remove contaminated clothing and jewelry and place them in plastic bags. Wash exposed areas with soap and water for 10 to 15 minutes with gentle sponging to avoid skin breakdown. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).

Range Of Toxicity

    A) TOXICITY: INSOLUBLE SALTS: A mouthful of the Araceae group plants may occasionally cause pain, edema, and swelling of the oral pharynx. SOLUBLE SALTS: Significant poisoning by rhubarb and sorrel has been reported only after ingestion of a sufficient quantity, such as used in food. This is more likely to occur in animals than in humans.
    B) STAR FRUIT: Two men developed acute oxalate nephropathy following the ingestion of 13.1 and 9.2 g of oxalate (in star fruit juice), respectively. Ingestion of half a star fruit has caused toxicity in a patient with chronic renal failure. However, the amount ingested and the onset of symptoms is highly variable.
    C) SORREL: A death was reported in an adult after ingestion of 500 g of the plant in a soup.

Summary Of Exposure

    A) BACKGROUND: SPECIES: Members of this group include dieffenbachia, elephant's ear, skunk cabbage, rhubarb leaves, philodendron, Averrhoa carambola (star fruit), caladium, etc., and in general most members of the arum group. All are members of the family Araceae (Arum), except a few members such as rhubarb and sorrel. Local symptoms are more common following dieffenbachia exposure.
    B) TOXICOLOGY: Family: Araceae: Dieffenbachia, Elephant's Ear, Caladiums, Calla Palustris (Water Dragon): Toxin: Raphides of water-insoluble calcium oxalate and unverified proteinaceous toxins. Family Polygonaceae: Rhubarb: Toxin: Anthraquinone glycosides and soluble oxalates. Family: Oxalidaceae (ie, Averrhoa carambola [star fruit}): Toxin: an oxalate that can produce neurotoxicity.
    C) EPIDEMIOLOGY: In most cases, exposure is due to common household plants. Exposure is likely to occur in young patients; severe toxicity is unlikely to occur.
    D) WITH POISONING/EXPOSURE
    1) EXPOSURE: PLANT TOXICITY: Plants containing oxalates usually are divided into 2 general categories: INSOLUBLE SALTS: Plants containing large amounts of needle-like calcium oxalate are not generally ingested in large enough quantities to produce systemic intoxication. Symptoms, when they occur, are generally local, manifesting as oral injury. A painful burning sensation of the lips and mouth following ingestion, inflammatory response often occurs and hoarseness, dysphonia and dysphagia may develop. Large quantities, if ingested, may produce some of the symptoms of the soluble salt plants. SOLUBLE SALTS: Plants with sodium or potassium salts may occasionally be eaten in sufficient quantities to produce systemic intoxication. Absorption is more likely with these plants since little mouth pain occurs, unlike the plants with crystal needles. Onset of symptoms is generally 2 to 12 hours. Renal, myocardial, brain, and liver damage is possible, as is gastroenteritis (ie, nausea, vomiting, diarrhea and abdominal pain). Seizures and coma have been reported after ingestion of star fruit by patients with a history of renal impairment.

Vital Signs

    3.3.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) HYPOTHERMIA: After the ingestion of 3 star fruits, a 60-year-old man with chronic renal failure developed hypothermia (temperature 30.4 degrees C). His temperature returned to normal after rewarming and two sessions of hemodialysis (Chen et al, 2005).

Heent

    3.4.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) INSOLUBLE SALTS: Irritation of the oral mucosa, including the mouth, tongue and throat occur, but in less than 20% of patients who have an oral exposure.
    2) INSOLUBLE SALTS: Ocular exposure to expressed sap may cause immediate pain, lacrimation, photophobia, corneal abrasions, and deposition of calcium oxalate crystals on the corneal epithelium.
    3.4.3) EYES
    A) WITH POISONING/EXPOSURE
    1) INSOLUBLE SALTS: Ocular exposure to expressed sap may cause immediate pain, lacrimation, photophobia, corneal abrasions, and deposition of calcium oxalate crystals on the corneal epithelium.
    2) VISION CHANGES: One patient experienced vision changes after ingesting plant material containing raphides (Watson et al, 2005).
    3.4.4) EARS
    A) WITH POISONING/EXPOSURE
    1) Hearing impairment has been reported after the ingestion of star fruit (carambola) (Chen et al, 2005).
    3.4.6) THROAT
    A) WITH POISONING/EXPOSURE
    1) Irritation of the oral mucosa, including the mouth, tongue and throat occur, but in less than 20% of patients who have an oral exposure. Respiratory distress is rare and may occur if edema of the tongue and oropharynx is severe (Cumpston et al, 2003; Watson et al, 2005; Drach & Maloney, 1963; Mrvos et al, 1991). Following ingestions of Caladium spp, oral irritation was reported in 70% of patients and throat irritation in 7% (Mrvos et al, 2001).
    2) SALIVATION: Profuse salivation is commonly noted (Watson et al, 2005; Drach & Maloney, 1963).
    3) DIEFFENBACHIA: A 9-year-old boy chewed on the leaf and stem of a Dieffenbachia plant and developed pain in the mouth, difficulty swallowing and drooling. Upon admission he complained of upper abdominal pain. The airway was patent without compromise. He was treated with IV fluids, analgesics, antacids, antihistamines and ranitidine. Mouth pain was severe enough that the patient did not take anything orally for 2 days; gradually the pain resolved along with sloughing of the tongue. He was discharged on day 4 and made a complete recovery (Adhikari, 2012).
    4) DIEFFENBACHIA/AIRWAY COMPROMISE: A 69-year-old man mistook a Dieffenbachia plant for 'sugar cane' and bit into the stem of the plant and immediately developed oral pain. He did not swallow any plant juice. Drooling and difficulty swallowing along with swelling of the lips, soft palate, uvula and tongue soon developed; the lungs remained clear. An x-ray of the neck showed marked laryngeal edema and enlargement of the epiglottis. Over the next hour, dyspnea and stridor occurred. The patient failed to respond to steroid and nebulized albuterol therapy requiring an emergent tracheostomy. The patient went on to develop bilateral pneumothoraces (25% on left and 35% on right, respectively) necessitating bilateral chest tubes. Over the next few days, the patient improved and the tracheostomy was capped on day 3. No permanent sequelae occurred (Cumpston et al, 2003).
    5) ALOCASIA ODORA: A 43-year-old woman bit into the root stock of an A odora plant (confirmed by an agricultural expert) while inebriated and presented 2 hours after exposure. Upon admission, she was alert and oriented with complaint of oral numbness, dyspnea and throat discomfort. She required endotracheal intubation for a swollen uvular and epiglottis; and received IV chlorpheniramine and methylprednisolone. The patient was extubated 12 hours later with mild swelling of the arytenoids and epiglottis with no respiratory complaints. However, the patient continued to complain of oral numbness and severe tongue pain and was transferred to a local hospital for further pain control and nutritional support (Moon et al, 2011).
    a) In another case, a man tasted the root of the same plant and developed oral numbness, pain of the tongue and nausea about 2 hours after exposure. The throat appeared slightly inflamed. Morphine was given for pain. Approximately 7 hours after presentation, the patient left against medical advice still complaining of severe tongue pain (Moon et al, 2011).
    6) CASE REPORT: A 2-year-old boy with a history of pica, associated with iron deficiency anemia, developed an acute episode of sialorrhea, difficulty in speaking, dysphagia, and repeated swallowing movements after ingesting a leaf from a Colocasia esculenta (elephant's ear). Following 2 days of close observation, he recovered and was discharged home in good health (Mihailidou et al, 2002).
    7) METALLIC TASTE: Three patients experienced metallic taste after ingesting plant material containing raphides (Watson et al, 2005).

Cardiovascular

    3.5.2) CLINICAL EFFECTS
    A) CONDUCTION DISORDER OF THE HEART
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Following large ingestions of soluble oxalates, oxalic acid is formed in the stomach and subsequently absorbed into the systemic circulation. There it binds with calcium, potentially resulting in hypocalcemia. This may rarely lead to weak, irregular pulse, bradycardia, hypotension and cardiac dysrhythmias (Tagwireyi & Ball, 2001). Rhythm disturbances, progressed to ventricular fibrillation, in a hypocalcemic (total calcium 6.3 mg/dL, ionized 2.3 mg/dL) patient (Farre et al, 1989).

Respiratory

    3.6.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) INSOLUBLE SALTS: Respiratory distress may occur if edema of the tongue and oropharynx is severe.
    2) SOLUBLE SALTS: Plants with sodium or potassium salts of oxalic acid, if eaten in sufficient quantities may produce systemic intoxication (Boston ivy, rhubarb leaves, Virginia creeper). Absorption is more likely with these plants since little oral irritation occurs.
    3.6.2) CLINICAL EFFECTS
    A) DYSPNEA
    1) WITH POISONING/EXPOSURE
    a) INSOLUBLE SALTS: Respiratory distress, requiring endotracheal intubation, may occur if edema of the tongue and oropharynx is severe (Tagwireyi & Ball, 2001; McIntire et al, 1990).
    b) ALOCASIA ODORA: A 43-year-old woman bit into the root stock of an A odora plant while inebriated and presented 2 hours after exposure. She was alert and oriented with complaint of oral numbness, dyspnea and throat discomfort. During endotracheal intubation, a swollen uvular and epiglottis were noted. Treatment included IV chlorpheniramine and methylprednisolone. Chest x-ray and laboratories studies were within normal limits with only mild leukocytosis. The patient was extubated 12 hours later with mild swelling of the arytenoids and epiglottis with no respiratory complaints. However, the patient continued to complain of oral numbness and tongue pain and was transferred to a local hospital for further pain control and nutritional support (Moon et al, 2011).
    B) ACUTE RESPIRATORY INSUFFICIENCY
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Dyspnea has been reported following toxicity due to soluble oxalate salts. Patients with preexisting renal failure are more prone to toxic effects (Chen et al, 2005; Chang et al, 2000). Respiratory depression requiring ventilation was noted in a comatose patient with acidosis and liver and kidney failure (Farre et al, 1989).
    C) ACUTE LUNG INJURY
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Pulmonary edema was seen in a fatality due to ingestion of Rumex crispus. Kidney failure was also present (Reig et al, 1990). Two cases of pulmonary edema complicating renal failure were reported following the ingestion of star fruit (Chen et al, 2001).

Neurologic

    3.7.2) CLINICAL EFFECTS
    A) TETANY
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Ingestion of large quantities of plants containing sodium or potassium oxalates may produce hypocalcemic tetany secondary to complexation of ionized calcium with oxalic acid. About 600 mg of oxalic acid is equal to total blood calcium (Sanz & Reig, 1992).
    B) COMA
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Disturbance of consciousness, including coma, has been reported after the toxic ingestion of soluble oxalate salts. Patients who ingest this on an empty stomach or who are dehydrated or who have preexisting renal failure are more prone to the CNS depressant effects. Coma is common in patients with chronic renal failure who ingest star fruit (Tse et al, 2003; Tsai et al, 2005; Chen et al, 2005; Chang et al, 2002; Chang et al, 2000; Neto et al, 1998). In one case, deep coma was reported after ingestion of soluble oxalates; the patient had hypocalcemia and kidney and liver failure (Farre et al, 1989).
    b) CASE REPORT: A 72-year-old diabetic dialysis patient developed nausea, vomiting, limb weakness, and disorientation after the ingestion of half a star fruit the day before. The next day, he was found unarousable with a GCS score of 3 of 15 with a positive Babinski's sign of the right foot, and intermittent hiccups. A brain CT scan did not show any specific abnormality except for mild brain atrophy; however, diffusion-weighted magnetic resonance imaging revealed hyperintense lesions in the left central regions. An EEG examination revealed found active focal sharp waves in the left central region that were compatible with nonconvulsive status epilepticus. Following anticonvulsant therapy and regular hemodialysis, he recovered and was discharged on the 20th day of hospitalization (Chang & Yeh, 2004).
    c) CASE SERIES: In a study of 7 consecutive uraemic patients (5 patients were receiving peritoneal dialysis; 1 patient was on hemodialysis) each developed varying degrees of toxicity following star fruit ingestion. Symptoms included hiccup, confusion, vomiting, impaired consciousness, muscle twitching and hyperkalemia. The average onset of symptoms was 8 hours. Of the 7 patients, 5 required an increase in dialysis for several days with notable improvement in symptoms. All cases had high oxalate concentrations which likely led to oxalosis and the neurologic effects observed. No deaths were reported (Tse et al, 2003).
    C) SEIZURE
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Seizures were seen in a pediatric patient experiencing renal impairment and electrolyte imbalance after rhubarb leaf ingestion (Kalliala & Kauste, 1964). Star fruit, a soluble oxalate, is reported to contain an unknown neurotoxin; in toxic doses, or in patients compromised with renal dysfunction, seizures have been reported (Chen et al, 2010; Yap et al, 2002; Chang et al, 2000).
    b) CASE REPORT: A 67-year-old woman with diabetes mellitus and moderate renal insufficiency developed altered mental status including coma and seizures one day after ingesting a star fruit. A MRI showed a reversible focal cerebral lesion over the left occipital area. She was treated symptomatically and was started on hemodialysis and gradually regained consciousness. A repeat MRI approximately 2 weeks after exposure showed resolution of the lesion. No permanent sequelae developed (Chen et al, 2010).
    c) CASE REPORT: A 52-year-old man with hypertension and chronic renal polycystic disease receiving hemodialysis developed a sudden onset of hiccoughs, an increase in blood pressure, seizures and confusion approximately 12 hours after ingesting a large amount of star fruit. A neurologic exam revealed severe ataxia, tetraparesis, loss of a gag reflex and bilateral ophthalmoparesis. A head CT was negative for a brain hemorrhage. Laboratory abnormalities included a plasma serum creatinine of 10.8 mg/dL, urea 209 mg/dL and metabolic acidosis (pH 6.84 and bicarbonate 6 mmol/L). The patient was placed on immediate hemodialysis for 18 hours and his neurologic function improved. A follow-up MRI showed no evidence of an acute cerebral ischemic event (Alessio-Alves et al, 2012).
    d) CASE REPORT: A 72-year-old diabetic dialysis patient developed nausea, vomiting, limb weakness, and disorientation after the ingestion of half a star fruit the day before. The next day, he was found unarousable with a GCS score of 3 of 15 with a positive Babinski's sign of the right foot, and intermittent hiccups. A brain CT scan did not show any specific abnormality except for mild brain atrophy; however diffusion-weighted magnetic resonance imaging revealed hyperintense lesions in the left central regions. An EEG examination revealed found active focal sharp waves in the left central region and that were compatible with nonconvulsive status epilepticus. Following anticonvulsant therapy and regular hemodialysis, he recovered and was discharged on the 20th day of hospitalization (Chang & Yeh, 2004).
    e) STATUS EPILEPTICUS: Refractory status epilepticus was reported in two elderly patients with chronic renal insufficiency, not dialysis dependent, (an 84-year-old woman and a 74-year-old man) after consuming 2 to 3 star fruit. Despite performing emergent hemodialysis, both patients died on day 23 and on day 7, respectively, of hospital admission (Tsai et al, 2005).
    1) The development of seizures after star fruit intoxication is a associated with a poor prognosis. In a retrospective analysis of 53 published cases of star fruit intoxication in patients with chronic renal insufficiency, 16 patients developed seizures. In these 16 patients, the mortality rate was 75% compared with 0.03% mortality rate of the 37 patients who did not present with seizures (Tsai et al, 2005).
    f) DIOSCOREA QUINQUELOBA: A 51-year-old healthy man ingested about 400 mL of the juice of raw tubers (D. quinqueloba) for general health and the following day he developed nausea and continuous vomiting. His wife drank a small amount of the juice and developed similar symptoms but the effects were milder and resolved a short time later. Upon admission his vital signs and laboratory studies were within normal limits. By the following day, his serum creatinine (Cr) was 2.9 mg/dL with a BUN of 42.7 mg/dL. On day 3, he was febrile (39 degrees Celsius) and developed a tonic-clonic seizure and a decreased level of consciousness. An EEG showed evidence of nonspecific and diffuse cerebral dysfunction and high anion gap metabolic acidosis was present. The patient was intubated and sedated and emergency hemodialysis was begun. By day 5, his BUN was 88.8 mg/dL and Cr was 8.6 mg/dL. He was then placed on continuous venovenous hemodiafiltration (CVVHDF) and his kidney function gradually improved. On day 12, CVVHDF was stopped and he was successfully extubated due to improved consciousness. He continued to receive supportive care and was discharged to home on day 26 with a BUN of 8.4 mg/dL and a Cr of 1.2 mg/dL (Kang & Heo, 2015).
    D) CEREBRAL EDEMA
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Cerebral edema may occur (Arana, 1986).
    E) PARESTHESIA
    1) WITH POISONING/EXPOSURE
    a) Oral paresthesia, with severe pain and numbness in the perioral area and throat has been reported following ingestions of oxalate containing plants (Chan et al, 1995). Focal neurological defects are not usually present. The paresthesia is generally mild with resolution over 5 days.
    F) PSYCHOMOTOR AGITATION
    1) WITH POISONING/EXPOSURE
    a) Agitation, incoherent speech, insomnia and mental confusion have been reported after the ingestion of soluble oxalates, particularly star fruit (carambola) (Tsai et al, 2005; Chang et al, 2002; Yap et al, 2002; Neto et al, 1998).
    G) MUSCLE WEAKNESS
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Muscle weakness and extremity numbness have been reported following ingestions of star fruit. Patients with pre-existing renal failure are particularly susceptible to neurological effects of this plant (Chang et al, 2000).
    H) HEADACHE
    1) WITH POISONING/EXPOSURE
    a) Three patients experienced headache after ingesting plant material containing raphides (Watson et al, 2005).
    3.7.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) SEIZURES
    a) RATS: Injections of an extract of star fruit provoked persistent tonic-clonic seizures in rats (Neto et al, 1998).

Gastrointestinal

    3.8.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) Adverse sequelae are uncommon following oral exposure to plants that contain insoluble calcium oxalate crystals. Rare reports described the development of edema, vesicles and lesions on the lips, tongue, esophagus and glottis.
    3.8.2) CLINICAL EFFECTS
    A) GASTROENTERITIS
    1) WITH POISONING/EXPOSURE
    a) Nausea, vomiting, abdominal pain and diarrhea may occur with either type salt. Bloody emesis and diarrhea may occur with soluble salts. Vomiting may be profuse (Tsai et al, 2005; Chang & Yeh, 2004; Yap et al, 2002; Chang et al, 2002; Neto et al, 1998; Chan et al, 1995; Farre et al, 1989; Kalliala & Kauste, 1964; Streicher, 1964).
    B) GASTROINTESTINAL IRRITATION
    1) WITH POISONING/EXPOSURE
    a) Contact with insoluble calcium oxalate crystals is not usually associated with the development of symptoms and rarely causes severe symptoms. Two large case series involving exposure to philodendrons and Dieffenbachias reported the incidence of minor symptoms to be 2.1% (Mrvos et al, 1991) to 15.5% (Krenzelok et al, 1996).
    1) A review of the symptoms associated with dieffenbachia exposure showed an incidence of oral irritation to be 18.2% (Pedaci et al, 1999 (in press)). Rare reports described the development of edema, vesicles and lesions on the lips, tongue, esophagus and glottis (Gardner, 1994).
    b) CASE SERIES: Lin et al (1998) described a case series of 25 patients who consumed a portion (1 to 2 mouthfuls) of the plant, alocasis macrorrhiza (giant elephant's ear). Onset of symptoms were almost immediate, with 18 patients developing throat irritation, 12 patients complained of numbness of the oral cavity, 6 patients had abdominal pain, 4 patients had difficulty speaking, 4 patients experienced excess salivation, 1 patient had dysphagia and 1 patient had swollen lips. All were described as mild poisonings, with symptoms resolving over one week (Lin et al, 1998).
    c) CASE REPORT: After eating the root tuber of Alocasia macrorrhiza, a 29-year-old man presented with numbness, paresthesia and pain over his tongue, oral cavity and throat. Symptoms cleared within 5 days (Chan et al, 1995).
    C) HICCOUGHS
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Intractable hiccups have commonly been reported following toxic ingestions of star fruit in patients with renal insufficiency (Alessio-Alves et al, 2012; Tsai et al, 2005; Chen et al, 2005; Chang & Yeh, 2004; Yap et al, 2002; Chang et al, 2002; Chang et al, 2000; Neto et al, 1998).
    D) DYSPHAGIA
    1) WITH POISONING/EXPOSURE
    a) CASE REPORT: A 2-year-old boy with a history of pica, associated with iron deficiency anemia, developed an acute episode of sialorrhea, difficulty in speaking, dysphagia, and repeated swallowing movements after ingesting a leaf from a Colocasia esculenta (elephant's ear). Following 2 days of close observation, he recovered and was discharged home in good health (Mihailidou et al, 2002).

Hepatic

    3.9.2) CLINICAL EFFECTS
    A) HEPATIC NECROSIS
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Centrilobular necrosis was seen in a fatality from R. crispus. The patient was an insulin-dependent diabetic and heavy smoker and drinker (Farre et al, 1989). A screen for other hepatotoxins was negative.
    b) Liver enlargement and slight icterus were seen in a 4-year-old and 6-year-old who ate 20 to 100 g of stems and leaves of rhubarb (Streicher, 1964).
    3.9.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) HEPATOCELLULAR DAMAGE
    a) LIVER CONGESTION: Livestock animals poisoned with Alocasia macrorrhiza were found to have liver congestion (Morton, 1971).

Genitourinary

    3.10.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) SOLUBLE SALTS: Renal damage may be noted following ingestion of soluble oxalates. This complication is uncommon in humans and generally occurs in animals after the ingestion of a large quantity of plant material. The development of symptoms may require 24 to 48 hours before symptomatology begins.
    3.10.2) CLINICAL EFFECTS
    A) ACUTE RENAL FAILURE SYNDROME
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Renal damage may be noted following ingestion of plants containing soluble oxalates (Reig et al, 1990; Tallqvist & Vaananen, 1960). Renal damage is uncommon but careful follow-up is indicated (Farre et al, 1989; Franceschi & Horner, 1980). These cases may require 2 to 48 hours before significant symptomatology begins.
    1) RHUBARB
    a) CASE REPORT: A 52-year-old woman with a history of type 1 diabetes and normal renal function was admitted with severe hypoglycemia and episodes of nausea and vomiting. Serum creatinine was 3.6 mg/dL. A renal biopsy showed mild mesangial sclerosis, but prominent tubular deposition of oxalate crystals in the kidney. She reported a recent ingestion of fresh rhubarb (500 mg) daily for approximately 4 weeks prior to admission. Serum oxalate levels were obtained and were elevated (13.75 micromol/L; reference range: less than 6.5 micromol/L); urinary oxalate levels were normal. The patient was started on IV fluids for the treatment of secondary oxalosis. Creatinine levels improved but slowly rose with the discontinuation of IV fluids and the patient was further treated for end-stage renal disease and was to start on hemodialysis (Albersmeyer et al, 2012).
    2) STAR FRUIT
    a) STAR FRUIT: Patients with a history of renal insufficiency may be more at risk to develop toxicity following a large ingestion of star fruit on an empty stomach (Lee, 2012).
    b) CASE REPORT: Acute oxalate nephropathy was reported after ingestion of 1600 mL of pure sour carambola juice (star fruit) in a previously healthy 77-year-old man. He drank the juice on an empty stomach, with initial symptoms occurring within hours. Renal biopsy revealed numerous, colorless oxalate crystals. After hemodialysis the patient improved. A 38-year-old previously healthy man also developed acute oxalate nephropathy after drinking 3000 mL of sour carambola juice on an empty stomach. He improved following hemodialysis (Chen et al, 2001).
    c) Severe renal lesions may produce proteinuria, oliguria, albuminuria, and anuria (Sanz & Reig, 1992).
    d) CASE REPORT: One day after ingesting 3 star fruits (about 60 g per star fruit), a 60-year-old man with diabetes mellitus, hypertension, alcoholic cirrhosis, chronic renal failure (baseline serum creatinine 5.7 mg/dL) developed chills, hiccups, tremor, irritability, hearing impairment, urinary retention, acute renal failure (creatinine 7.3 mg/dL; BUN 89 mg/dL), acute respiratory failure, coma and hypothermia (30.4 degrees C). Urinalysis showed proteinuria, glycosuria, and microhematuria. Following 2 sessions of hemodialysis, his body temperature returned to normal, but he remained comatose. After a 6-hour session of charcoal hemoperfusion, his consciousness returned to normal within a day (Chen et al, 2005).
    3) DIOSCOREA SPECIES/YAMS
    a) DIOSCOREA QUINQUELOBA: A 51-year-old healthy man ingested about 400 mL of the juice of raw tubers (D. quinqueloba) for general health and the following day he developed nausea and continuous vomiting. His wife drank a small amount of the juice and developed similar symptoms but the effects were milder and resolved a short time later. Upon admission his vital signs and laboratory studies were within normal limits. By the following day, his serum creatinine (Cr) was 2.9 mg/dL with a BUN of 42.7 mg/dL. On day 3, he was febrile (39 degrees Celsius) and developed a tonic-clonic seizure and a decreased level of consciousness. An EEG showed evidence of nonspecific and diffuse cerebral dysfunction and high anion gap metabolic acidosis was present. The patient was intubated and sedated and emergency hemodialysis was begun. By day 5, his BUN was 88.8 mg/dL and Cr was 8.6 mg/dL. He was then placed on continuous venovenous hemodiafiltration (CVVHDF) and his kidney function gradually improved. On day 12, CVVHDF was stopped and he was successfully extubated due to improved consciousness. He continued to receive supportive care and was discharged to home on day 26 with a BUN of 8.4 mg/dL and a Cr of 1.2 mg/dL (Kang & Heo, 2015).
    b) DIOSCOREA QUNQUELOBA: A 68-year-old man started taking an extract containing D. quinqueloba for about a week for diabetes mellitus. Upon admission, he was oliguric with pitting edema of his lower extremities. His initial laboratory studies revealed a serum creatinine level of 4.6 mg/dL, creatinine kinase 66 Units/L (normal range, 35 to 172), sodium 133 mEq/L, potassium of 4.7 mEq/L and a BUN of 56.6 mg/dL. Urine sodium and creatinine were 50 mEq/L and 32.2 mg/dL, respectively. Hydration therapy was initiated. His creatinine gradually declined from 5.9 to 1.2 mg/dL. By day 6, he was discharged without permanent sequelae. In the second case, the 58 year-old brother of case 1 also developed pitting edema of his lower extremities, vomiting, diarrhea and polydipsia after taking the same D. quinqueloba extract for general well being. His serum creatinine level (5.8 mg/dL) and BUN (48.2 mg/dL) were both elevated. Similarly, he was diagnosed with intrinsic acute renal failure and treated with hydration therapy. His renal function gradually improved and his creatinine level decreased to 1.3 mg/dL approximately 10 days after admission (Kim et al, 2012).
    b) HISTOLOGY: Renal lesions appear as small hemorrhages, congestion, cellular cloudy swelling, sclerosis and hyalin degeneration of the tubules, and lesions associated with interstitial tubular glomerulonephrosis (Bottarelli, 1968).
    B) TUBULOINTERSTITIAL NEPHRITIS
    1) WITH POISONING/EXPOSURE
    a) RUMEX ACETOSA/CASE REPORT: A 12-year-old boy ingested a large amount of sorrel (rumex acetosa) while playing in a field and developed acute tubulointerstitial nephritis. Although the amount was unknown, he continued to eat the plant until he felt full and developed mouth soreness. Initially, vomiting was the only reported symptom. Eighteen days later, he was admitted with polyuria. Laboratory studies were normal with the exception of hypophosphatemia and mildly elevated serum transaminase levels. Proteinuria and glucosuria were also present. A renal ultrasonography confirmed an increase echogenicity of both kidneys that was suggestive of proximal tubulopathy. Further urine testing was positive for oxalate (116 mg/1.73 m(2)/day; normal less than 45 mg/1.73 m(2)/day). Following oral rehydration and electrolyte replacement, the patient clinically improved and laboratory studies normalized within a few weeks. Although a renal biopsy would have been confirmatory, it was not performed due to the child's rapid clinical improvement with supportive therapy (Selcuk et al, 2015).
    C) NEPHRITIS
    1) WITH POISONING/EXPOSURE
    a) Nephritis is more common among people who use Colocasia and Xanthosoma species as a food crop (Kasilo, 1990).
    D) BLOOD IN URINE
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Hematuria and oxaluria were seen several hours after a 16-year-old boy ingested 3 enormous helpings of red currants. Oxalate crystals were seen in the urine. No sequelae were seen (Vicary, 1977).
    3.10.3) ANIMAL EFFECTS
    A) ANIMAL STUDIES
    1) NEPHROPATHY
    a) RATS: An acute oxalate nephropathy was induced by sour star fruit juice feedings in rats. The oxalate concentration in the juice was 2.46 g/dL; the rats received 4 mL/100 g body weight (or approximately 1 g oxalate/kg). Pathological examination of the kidney revealed extensive refractile oxalate crystals in some tubules (Fang et al, 2001).

Acid-Base

    3.11.2) CLINICAL EFFECTS
    A) ACIDOSIS
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: METABOLIC ACIDOSIS was noted in a patient who died after ingesting 500 g of sorrel (Farre et al, 1989).
    b) STAR FRUIT: A 52-year-old man with hypertension and chronic renal polycystic disease receiving hemodialysis developed a sudden onset of hiccoughs, an increase in blood pressure, seizures and confusion approximately 12 hours after ingesting a large amount of star fruit. A neurologic exam revealed severe ataxia, tetraparesis, loss of a gag reflex and bilateral ophthalmoparesis. A head CT was negative for a brain hemorrhage. Laboratory abnormalities included metabolic acidosis (pH 6.84 and bicarbonate 6 mmol/L), a plasma serum creatinine of 10.8 mg/dL and urea 209 mg/dL. The patient was placed on immediate hemodialysis for 18 hours and his neurologic function improved. A follow-up MRI showed no evidence of an acute cerebral ischemic event (Alessio-Alves et al, 2012).

Musculoskeletal

    3.15.1) SUMMARY
    A) WITH POISONING/EXPOSURE
    1) SOLUBLE SALTS: Tetany and muscle cramps may occur following ingestion.
    3.15.2) CLINICAL EFFECTS
    A) TETANY
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Hypocalcemic tetany may occur following ingestion of plants containing soluble oxalates. The common gastrointestinal signs may be seen earlier.
    B) INCREASED MUSCLE TONE
    1) WITH POISONING/EXPOSURE
    a) SOLUBLE SALTS: Muscle cramps may result due to hypocalcemia following a toxic plant ingestion (Tagwireyi & Ball, 2001).

Monitoring Parameters Levels

    4.1.1) SUMMARY
    A) Routine laboratory studies are not indicated.
    B) For diagnostic purposes in patients with severe poisoning, examine the urine for calcium oxalate crystals. This should not be performed routinely. Monitor calcium and renal function (BUN, creatinine).
    4.1.2) SERUM/BLOOD
    A) BLOOD/SERUM CHEMISTRY
    1) Monitor calcium and liver function.
    2) Renal function such as BUN and creatinine should be monitored in the delayed effects group.
    B) ACID/BASE
    1) Monitor acid-base status.
    4.1.3) URINE
    A) URINALYSIS
    1) In cases of severe poisoning where diagnosis is in question, the urine may be analyzed for the presence of calcium oxalate crystals.

Methods

    A) MULTIPLE ANALYTICAL METHODS
    1) CRYSTAL IDENTIFICATION
    a) Tissue crystal identification can be done with the microscope using polarized light. Oxalates are birefringent under polarized light.
    b) Methods of chemical identification were discussed by Johnson & Pani (1962). They involve van Kossa's method or tissue incineration.
    c) Calcium vs other oxalates can be differentiated by analysis of birefringent crystals with a scanning electron microscope with x-ray energy dispersion (Reig et al, 1990).

Life Support

    A) Support respiratory and cardiovascular function.

Patient Disposition

    6.3.1) DISPOSITION/ORAL EXPOSURE
    6.3.1.1) ADMISSION CRITERIA/ORAL
    A) Patients who present with severe symptoms (ie, significant drooling or laryngeal swelling, respiratory distress, seizure activity, renal impairment) should be admitted to an intensive care setting. Also, admit patients with persistent symptoms that have not responded to therapy.
    6.3.1.2) HOME CRITERIA/ORAL
    A) Asymptomatic or mild oral pain/irritation in a child with a minor taste ingestion can be managed at home with a responsible adult. Any increase in pain or evidence of drooling requires immediate further evaluation.
    6.3.1.3) CONSULT CRITERIA/ORAL
    A) Consult a medical toxicologist or poison center if the diagnosis is unclear.
    6.3.1.5) OBSERVATION CRITERIA/ORAL
    A) Any patient who develops drooling, difficulty swallowing or more than mild symptoms (ie, ongoing or severe pain) should be sent to a healthcare facility for evaluation and treatment. If symptoms resolve completely in the emergency department, the patient may be discharged to home following psychiatric clearance as needed.

Monitoring

    A) Routine laboratory studies are not indicated.
    B) For diagnostic purposes in patients with severe poisoning, examine the urine for calcium oxalate crystals. This should not be performed routinely. Monitor calcium and renal function (BUN, creatinine).

Oral Exposure

    6.5.1) PREVENTION OF ABSORPTION/PREHOSPITAL
    A) DILUTION
    1) Remove all visible evidence of plant debris from the oropharynx and administer milk or water to rinse out crystals and assist with oropharynx decontamination.
    6.5.2) PREVENTION OF ABSORPTION
    A) DILUTION
    1) Remove all visible evidence of plant debris from the oropharynx and administer milk or water to rinse out crystals and assist with oropharynx decontamination.
    B) GASTRIC LAVAGE
    1) NOT RECOMMENDED: Gastric lavage is probably of NO value since it may be difficult to retrieve large amounts of plant material via a gastric lavage tube.
    6.5.3) TREATMENT
    A) OXALATE SALT
    1) INSOLUBLE SALTS
    a) DILUTION: Remove all visible evidence of plant (eg, caladium, dieffenbachia, elephant's ear) debris from the oropharynx and administer milk or water to rinse out crystals and assist with oropharynx decontamination. Most ingestions are not large enough to result in severe toxicity; following a taste of the plant, demulcents (milk or water) to rinse the mouth and/or ice, may be all that is necessary (Tagwireyi & Ball, 2001).
    b) ICE: Cold water or sucking on crushed ice will relieve oral pain. Popsicles are useful in children. Analgesic medication may be required for intense pain.
    2) SOLUBLE SALTS
    a) FLUID/ELECTROLYTES: Maintain adequate hydration with intravenous fluids if oral fluids cannot be tolerated.
    1) Maintain adequate urine flow if oxalate crystals are present.
    2) MONITORING PARAMETERS: For diagnostic purposes in patients with severe poisoning, examine the urine for calcium oxalate crystals. This should not be performed routinely. Monitor calcium and renal function.
    b) HYPOCALCEMIA and tetany should be treated with intravenous calcium gluconate (Tagwireyi & Ball, 2001; Gosselin et al, 1984).
    B) AIRWAY MANAGEMENT
    1) Airway support is unlikely to be necessary following a "taste" or mild exposure. However, difficulty swallowing, drooling and stridor have occurred following minor dieffenbachia plant exposure. Airway management may be necessary in patients who develop upper airway edema. Surgical airway (cricothyrotomy or tracheostomy) may be necessary in patients with severe upper airway edema.
    2) DIEFFENBACHIA/AIRWAY COMPROMISE: A 69-year-old man mistook a Dieffenbachia plant for 'sugar cane' and bit into the stem of the plant. Drooling and difficulty swallowing along with swelling of the lips, soft palate, uvula and tongue soon developed; the lungs remained clear. An x-ray of the neck showed marked laryngeal edema and enlargement of the epiglottis. Over the next hour, dyspnea and stridor occurred. The patient failed to respond to steroid and nebulized albuterol therapy requiring an emergent tracheostomy. His course was further complicated by bilateral pneumothoraces requiring bilateral chest tubes. Over the next few days, the patient improved and the tracheostomy was capped on day 3. No permanent sequelae occurred (Cumpston et al, 2003).
    C) SEIZURE
    1) SUMMARY
    a) SOLUBLE SALTS: Seizures were seen in a pediatric patient experiencing renal impairment and electrolyte imbalance after rhubarb leaf ingestion (Kalliala & Kauste, 1964). Star fruit, a soluble oxalate, is reported to contain an unknown neurotoxin; in toxic doses, or in patients compromised with renal dysfunction, seizures have been reported (Alessio-Alves et al, 2012; Yap et al, 2002; Chang et al, 2000).
    2) SUMMARY
    a) Attempt initial control with a benzodiazepine (eg, diazepam, lorazepam). If seizures persist or recur, administer phenobarbital or propofol.
    b) Monitor for respiratory depression, hypotension, and dysrhythmias. Endotracheal intubation should be performed in patients with persistent seizures.
    c) Evaluate for hypoxia, electrolyte disturbances, and hypoglycemia (or, if immediate bedside glucose testing is not available, treat with intravenous dextrose).
    3) DIAZEPAM
    a) ADULT DOSE: Initially 5 to 10 mg IV, OR 0.15 mg/kg IV up to 10 mg per dose up to a rate of 5 mg/minute; may be repeated every 5 to 20 minutes as needed (Brophy et al, 2012; Prod Info diazepam IM, IV injection, 2008; Manno, 2003).
    b) PEDIATRIC DOSE: 0.1 to 0.5 mg/kg IV over 2 to 5 minutes; up to a maximum of 10 mg/dose. May repeat dose every 5 to 10 minutes as needed (Loddenkemper & Goodkin, 2011; Hegenbarth & American Academy of Pediatrics Committee on Drugs, 2008).
    c) Monitor for hypotension, respiratory depression, and the need for endotracheal intubation. Consider a second agent if seizures persist or recur after repeated doses of diazepam .
    4) NO INTRAVENOUS ACCESS
    a) DIAZEPAM may be given rectally or intramuscularly (Manno, 2003). RECTAL DOSE: CHILD: Greater than 12 years: 0.2 mg/kg; 6 to 11 years: 0.3 mg/kg; 2 to 5 years: 0.5 mg/kg (Brophy et al, 2012).
    b) MIDAZOLAM has been used intramuscularly and intranasally, particularly in children when intravenous access has not been established. ADULT DOSE: 0.2 mg/kg IM, up to a maximum dose of 10 mg (Brophy et al, 2012). PEDIATRIC DOSE: INTRAMUSCULAR: 0.2 mg/kg IM, up to a maximum dose of 7 mg (Chamberlain et al, 1997) OR 10 mg IM (weight greater than 40 kg); 5 mg IM (weight 13 to 40 kg); INTRANASAL: 0.2 to 0.5 mg/kg up to a maximum of 10 mg/dose (Loddenkemper & Goodkin, 2011; Brophy et al, 2012). BUCCAL midazolam, 10 mg, has been used in adolescents and older children (5-years-old or more) to control seizures when intravenous access was not established (Scott et al, 1999).
    5) LORAZEPAM
    a) MAXIMUM RATE: The rate of intravenous administration of lorazepam should not exceed 2 mg/min (Brophy et al, 2012; Prod Info lorazepam IM, IV injection, 2008).
    b) ADULT DOSE: 2 to 4 mg IV initially; repeat every 5 to 10 minutes as needed, if seizures persist (Manno, 2003; Brophy et al, 2012).
    c) PEDIATRIC DOSE: 0.05 to 0.1 mg/kg IV over 2 to 5 minutes, up to a maximum of 4 mg/dose; may repeat in 5 to 15 minutes as needed, if seizures continue (Brophy et al, 2012; Loddenkemper & Goodkin, 2011; Hegenbarth & American Academy of Pediatrics Committee on Drugs, 2008; Sreenath et al, 2009; Chin et al, 2008).
    6) PHENOBARBITAL
    a) ADULT LOADING DOSE: 20 mg/kg IV at an infusion rate of 50 to 100 mg/minute IV. An additional 5 to 10 mg/kg dose may be given 10 minutes after loading infusion if seizures persist or recur (Brophy et al, 2012).
    b) Patients receiving high doses will require endotracheal intubation and may require vasopressor support (Brophy et al, 2012).
    c) PEDIATRIC LOADING DOSE: 20 mg/kg may be given as single or divided application (2 mg/kg/minute in children weighing less than 40 kg up to 100 mg/min in children weighing greater than 40 kg). A plasma concentration of about 20 mg/L will be achieved by this dose (Loddenkemper & Goodkin, 2011).
    d) REPEAT PEDIATRIC DOSE: Repeat doses of 5 to 20 mg/kg may be given every 15 to 20 minutes if seizures persist, with cardiorespiratory monitoring (Loddenkemper & Goodkin, 2011).
    e) MONITOR: For hypotension, respiratory depression, and the need for endotracheal intubation (Loddenkemper & Goodkin, 2011; Manno, 2003).
    f) SERUM CONCENTRATION MONITORING: Monitor serum concentrations over the next 12 to 24 hours. Therapeutic serum concentrations of phenobarbital range from 10 to 40 mcg/mL, although the optimal plasma concentration for some individuals may vary outside this range (Hvidberg & Dam, 1976; Choonara & Rane, 1990; AMA Department of Drugs, 1992).
    7) OTHER AGENTS
    a) If seizures persist after phenobarbital, propofol or pentobarbital infusion, or neuromuscular paralysis with general anesthesia (isoflurane) and continuous EEG monitoring should be considered (Manno, 2003). Other anticonvulsants can be considered (eg, valproate sodium, levetiracetam, lacosamide, topiramate) if seizures persist or recur; however, there is very little data regarding their use in toxin induced seizures, controlled trials are not available to define the optimal dosage ranges for these agents in status epilepticus (Brophy et al, 2012):
    1) VALPROATE SODIUM: ADULT DOSE: An initial dose of 20 to 40 mg/kg IV, at a rate of 3 to 6 mg/kg/minute; may give an additional dose of 20 mg/kg 10 minutes after loading infusion. PEDIATRIC DOSE: 1.5 to 3 mg/kg/minute (Brophy et al, 2012).
    2) LEVETIRACETAM: ADULT DOSE: 1000 to 3000 mg IV, at a rate of 2 to 5 mg/kg/min IV. PEDIATRIC DOSE: 20 to 60 mg/kg IV (Brophy et al, 2012; Loddenkemper & Goodkin, 2011).
    3) LACOSAMIDE: ADULT DOSE: 200 to 400 mg IV; 200 mg IV over 15 minutes (Brophy et al, 2012). PEDIATRIC DOSE: In one study, median starting doses of 1.3 mg/kg/day and maintenance doses of 4.7 mg/kg/day were used in children 8 years and older (Loddenkemper & Goodkin, 2011).
    4) TOPIRAMATE: ADULT DOSE: 200 to 400 mg nasogastric/orally OR 300 to 1600 mg/day orally divided in 2 to 4 times daily (Brophy et al, 2012).
    D) ACUTE ALLERGIC REACTION
    1) SUMMARY
    a) Mild to moderate allergic reactions may be treated with antihistamines with or without inhaled beta adrenergic agonists, corticosteroids or epinephrine. Treatment of severe anaphylaxis also includes oxygen supplementation, aggressive airway management, epinephrine, ECG monitoring, and IV fluids.
    2) BRONCHOSPASM
    a) ALBUTEROL
    1) ADULT: 2.5 to 5 milligrams in 2 to 4.5 milliliters of normal saline delivered per nebulizer every 20 minutes up to 3 doses. If incomplete response administer 2.5 to 10 mg every 1 to 4 hours as needed, or 10 to 15 mg/hr by continuous nebulization as needed (National Heart,Lung,and Blood Institute, 2007). CHILD: 0.15 milligram/kilogram (minimum 2.5 milligrams) per nebulizer every 20 minutes up to 3 doses. If incomplete response administer 0.15 to 0.3 mg/kg (up to 10 mg) every 1 to 4 hours as needed, or 0.5 mg/kg/hr by continuous nebulization (National Heart,Lung,and Blood Institute, 2007).
    3) CORTICOSTEROIDS
    a) Consider systemic corticosteroids in patients with significant bronchospasm.
    b) PREDNISONE: ADULT: 40 to 80 milligrams/day. CHILD: 1 to 2 milligrams/kilogram/day (maximum 60 mg) in 1 to 2 divided doses divided twice daily (National Heart,Lung,and Blood Institute, 2007).
    4) MILD CASES
    a) DIPHENHYDRAMINE
    1) SUMMARY: Oral diphenhydramine, as well as other H1 antihistamines can be used as indicated (Lieberman et al, 2010).
    2) ADULT: 50 milligrams orally, or 10 to 50 mg intravenously at a rate not to exceed 25 mg/min or may be given by deep intramuscular injection. A total of 100 mg may be administered if needed. Maximum daily dosage is 400 mg (Prod Info diphenhydramine HCl intravenous injection solution, intramuscular injection solution, 2013).
    3) CHILD: 5 mg/kg/24 hours or 150 mg/m(2)/24 hours. Divided into 4 doses, administered intravenously at a rate not exceeding 25 mg/min or by deep intramuscular injection. Maximum daily dosage is 300 mg (Prod Info diphenhydramine HCl intravenous injection solution, intramuscular injection solution, 2013).
    5) MODERATE CASES
    a) EPINEPHRINE: INJECTABLE SOLUTION: It should be administered early in patients by IM injection. Using a 1:1000 (1 mg/mL) solution of epinephrine. Initial Dose: 0.01 mg/kg intramuscularly with a maximum dose of 0.5 mg in adults and 0.3 mg in children. The dose may be repeated every 5 to 15 minutes, if no clinical improvement. Most patients respond to 1 or 2 doses (Nowak & Macias, 2014).
    6) SEVERE CASES
    a) EPINEPHRINE
    1) INTRAVENOUS BOLUS: ADULT: 1 mg intravenously as a 1:10,000 (0.1 mg/mL) solution; CHILD: 0.01 mL/kg intravenously to a maximum single dose of 1 mg given as a 1:10,000 (0.1 mg/mL) solution. It can be repeated every 3 to 5 minutes as needed. The dose can also be given by the intraosseous route if IV access cannot be established (Lieberman et al, 2015). ALTERNATIVE ROUTE: ENDOTRACHEAL ADMINISTRATION: If IV/IO access is unavailable. DOSE: ADULT: Administer 2 to 2.5 mg of 1:1000 (1 mg/mL) solution diluted in 5 to 10 mL of sterile water via endotracheal tube. CHILD: DOSE: 0.1 mg/kg to a maximum of 2.5 mg administered as a 1:1000 (1 mg/mL) solution diluted in 5 to 10 mL of sterile water via endotracheal tube (Lieberman et al, 2015).
    2) INTRAVENOUS INFUSION: Intravenous administration may be considered in patients poorly responsive to IM or SubQ epinephrine. An epinephrine infusion may be prepared by adding 1 mg (1 mL of 1:1000 (1 mg/mL) solution) to 250 mL D5W, yielding a concentration of 4 mcg/mL, and infuse this solution IV at a rate of 1 mcg/min to 10 mcg/min (maximum rate). CHILD: A dosage of 0.01 mg/kg (0.1 mL/kg of a 1:10,000 (0.1 mg/mL) solution up to 10 mcg/min (maximum dose 0.3 mg) is recommended for children (Lieberman et al, 2010). Careful titration of a continuous infusion of IV epinephrine, based on the severity of the reaction, along with a crystalloid infusion can be considered in the treatment of anaphylactic shock. It appears to be a reasonable alternative to IV boluses, if the patient is not in cardiac arrest (Vanden Hoek,TL,et al).
    7) AIRWAY MANAGEMENT
    a) OXYGEN: 5 to 10 liters/minute via high flow mask.
    b) INTUBATION: Perform early if any stridor or signs of airway obstruction.
    c) CRICOTHYROTOMY: Use if unable to intubate with complete airway obstruction (Vanden Hoek,TL,et al).
    d) BRONCHODILATORS are recommended for mild to severe bronchospasm.
    e) ALBUTEROL: ADULT: 2.5 to 5 milligrams in 2 to 4.5 milliliters of normal saline delivered per nebulizer every 20 minutes up to 3 doses. If incomplete response administer 2.5 to 10 mg every 1 to 4 hours as needed, or 10 to 15 mg/hr by continuous nebulization as needed (National Heart,Lung,and Blood Institute, 2007).
    f) ALBUTEROL: CHILD: 0.15 milligram/kilogram (minimum 2.5 milligrams) per nebulizer every 20 minutes up to 3 doses. If incomplete response administer 0.15 to 0.3 milligram/kilogram (maximum 10 milligrams) every 1 to 4 hours as needed OR administer 0.5 mg/kg/hr by continuous nebulization (National Heart,Lung,and Blood Institute, 2007).
    8) MONITORING
    a) CARDIAC MONITOR: All complicated cases.
    b) IV ACCESS: Routine in all complicated cases.
    9) HYPOTENSION
    a) If hypotensive give 500 to 2000 milliliters crystalloid initially (20 milliliters/kilogram in children) and titrate to desired effect (stabilization of vital signs, mentation, urine output); adults may require up to 6 to 10 L/24 hours. Central venous or pulmonary artery pressure monitoring is recommended in patients with persistent hypotension.
    1) VASOPRESSORS: Should be used in refractory cases unresponsive to repeated doses of epinephrine and after vigorous intravenous crystalloid rehydration (Lieberman et al, 2010).
    2) DOPAMINE: Initial Dose: 2 to 20 micrograms/kilogram/minute intravenously; titrate to maintain systolic blood pressure greater than 90 mm Hg (Lieberman et al, 2010).
    10) H1 and H2 ANTIHISTAMINES
    a) SUMMARY: Antihistamines are second-line therapy and are used as supportive therapy and should not be used in place of epinephrine (Lieberman et al, 2010).
    1) DIPHENHYDRAMINE: ADULT: 25 to 50 milligrams via a slow intravenous infusion or IM. PEDIATRIC: 1 milligram/kilogram via slow intravenous infusion or IM up to 50 mg in children (Lieberman et al, 2010).
    b) RANITIDINE: ADULT: 1 mg/kg parenterally; CHILD: 12.5 to 50 mg parenterally. If the intravenous route is used, ranitidine should be infused over 10 to 15 minutes or diluted in 5% dextrose to a volume of 20 mL and injected over 5 minutes (Lieberman et al, 2010).
    c) Oral diphenhydramine, as well as other H1 antihistamines, can also be used as indicated (Lieberman et al, 2010).
    11) DYSRHYTHMIAS
    a) Dysrhythmias and cardiac dysfunction may occur primarily or iatrogenically as a result of pharmacologic treatment (epinephrine) (Vanden Hoek,TL,et al). Monitor and correct serum electrolytes, oxygenation and tissue perfusion. Treat with antiarrhythmic agents as indicated.
    12) OTHER THERAPIES
    a) There have been a few reports of patients with anaphylaxis, with or without cardiac arrest, that have responded to vasopressin therapy that did not respond to standard therapy. Although there are no randomized controlled trials, other alternative vasoactive therapies (ie, vasopressin, norepinephrine, methoxamine, and metaraminol) may be considered in patients in cardiac arrest secondary to anaphylaxis that do not respond to epinephrine (Vanden Hoek,TL,et al).

Eye Exposure

    6.8.1) DECONTAMINATION
    A) EYE IRRIGATION, ROUTINE: Remove contact lenses and irrigate exposed eyes with copious amounts of room temperature 0.9% saline or water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist after 15 minutes of irrigation, an ophthalmologic examination should be performed (Peate, 2007; Naradzay & Barish, 2006).

Dermal Exposure

    6.9.1) DECONTAMINATION
    A) DECONTAMINATION: Remove contaminated clothing and wash exposed area thoroughly with soap and water for 10 to 15 minutes. A physician may need to examine the area if irritation or pain persists (Burgess et al, 1999).

Enhanced Elimination

    A) HEMODIALYSIS
    1) SUMMARY: Hemodialysis has been utilized in cases of severe acute oxalate nephropathy induced by ingestion of soluble oxalates in star fruit (Chen et al, 2001).
    2) CASE REPORT: Hemodialysis was done on a 6-year-old with renal insufficiency and albuminuria. The girl recovered; the effect of the hemodialysis on blood oxalate concentration was not measured (van Streicher, 1964).
    3) CASE REPORT: A 60-year-old man with chronic renal insufficiency developed severe toxicity (chills, hiccups, tremor, irritability, hearing impairment, acute renal and respiratory failure, coma, hypothermia) after ingesting 3 star fruits. He was treated with 2 sessions of hemodialysis, and a 6-hour session of charcoal hemoperfusion, and he recovered (Chen et al, 2005).
    B) HEMOPERFUSION
    1) SUMMARY: Hemoperfusion was associated with neurologic improvement in patients with a history of chronic renal disease who developed coma after the ingestion of star fruit (Chan et al, 2009; Wu et al, 2007; Chen et al, 2005).
    2) CASE REPORT: A 76-year-old woman with diabetes mellitus and chronic renal impairment she developed limb weakness and became mute about 4 hours after ingesting 2 star fruits. The patient developed seizure activity prior to arrival to the hospital and was in a coma upon admission. A brain MRI was normal. During admission she was intubated for airway protection and started on an 8-hour session of charcoal hemoperfusion followed by 30 hours of continuous hemofiltration. She also developed profound hypotension during hemoperfusion requiring inotropic support for 24-hours. The patient's neurologic status improved gradually with therapy and she was extubated without difficulty (Chan et al, 2009).
    3) CASE REPORTS: Two adults with chronic renal disease (stage 5) developed altered consciousness and coma following the ingestion of star fruit. Both received a course of hemodialysis on the first hospital day with no improvement in neurologic function. Consciousness improved within 16 to 20 hours of an 8-hour session of charcoal hemoperfusion at a blood flow circulation of 250 to 300 mL/minute. Ongoing neurologic recovery was observed and no permanent sequelae developed in either patient (Wu et al, 2007).
    4) CASE REPORTS: Charcoal hemoperfusion and sustained low-efficiency daily diafiltration (SLEDD-f) were used in 2 adults with a history of chronic renal disease that developed severe toxicity after ingesting star fruit. Seizure activity improved with therapy; however, improvement in clinical outcome did not occur. One patient remained unconscious and died of pneumonia and septicemia several months after hospitalization and the other patient remained comatose 48 days after admission (Wu et al, 2011).
    5) CASE REPORT: A 60-year-old man with chronic renal insufficiency developed severe toxicity (chills, hiccups, tremor, irritability, hearing impairment, acute renal and respiratory failure, coma, hypothermia) after ingesting 3 star fruits. He was treated with 2 sessions of hemodialysis, and a 6-hour session of charcoal hemoperfusion, and he recovered (Chen et al, 2005).

Case Reports

    A) ADULT
    1) A 53-year-old was admitted to the hospital after ingesting a soup with 500 g of sorrel (Rumex crispus). His symptoms were vomiting, diarrhea, metabolic acidosis, hypocalcemia and extensive liver cell necrosis. Soon after admission he lapsed into a coma and experienced respiratory depression, liver and kidney failure, acidosis and hypocalcemia. He developed arrhythmias leading to ventricular fibrillation. He died while on dialysis, two hours postadmission. Crystals of calcium oxalate were seen in the renal cortex and vessels and capillaries of the liver, lung, and heart (Farre et al, 1989).
    2) One day after ingesting 3 star fruits (about 60 g per star fruit), a 60-year-old man with diabetes mellitus, hypertension, alcoholic cirrhosis, chronic renal failure (baseline serum creatinine 5.7 mg/dL) developed chills, hiccups, tremor, irritability, hearing impairment, urinary retention, renal failure (creatinine 7.3 mg/dL; BUN 89 mg/dL), acute respiratory failure, coma and hypothermia (30.4 degrees C). Urinalysis showed proteinuria, glycosuria, and microhematuria. Following 2 sessions of hemodialysis and rewarming, his body temperature returned to normal, but he remained comatose. After a 6-hour session of charcoal hemoperfusion, his consciousness returned to normal within a day (Chen et al, 2005).

Summary

    A) TOXICITY: INSOLUBLE SALTS: A mouthful of the Araceae group plants may occasionally cause pain, edema, and swelling of the oral pharynx. SOLUBLE SALTS: Significant poisoning by rhubarb and sorrel has been reported only after ingestion of a sufficient quantity, such as used in food. This is more likely to occur in animals than in humans.
    B) STAR FRUIT: Two men developed acute oxalate nephropathy following the ingestion of 13.1 and 9.2 g of oxalate (in star fruit juice), respectively. Ingestion of half a star fruit has caused toxicity in a patient with chronic renal failure. However, the amount ingested and the onset of symptoms is highly variable.
    C) SORREL: A death was reported in an adult after ingestion of 500 g of the plant in a soup.

Minimum Lethal Exposure

    A) SUMMARY
    1) Hypocalcemia and tetany may occur due to combination of ionic calcium with oxalate. Approximately 600 mg of oxalic acid is equal to total blood calcium (Sanz & Reig, 1992).
    B) SOLUBLE SALTS
    1) RUMEX CRISPUS (Sorrel) (ADULT): 6 to 8 g of oxalic acid was ingested in soup containing Rumex crispus (500 g of sorrel). The patient died, and at necropsy, crystals of calcium oxalate were seen in renal cortex and vessels and capillaries of the liver, lung, and heart (Farre et al, 1989; Reig et al, 1990).

Maximum Tolerated Exposure

    A) SPECIFIC SUBSTANCE
    1) INSOLUBLE SALTS
    a) DIEFFENBACHIA: A mouthful of the Araceae group plants may cause pain, edema and swelling of the oropharynx. However, this is unusual. Two case series involving exposure to philodendrons and Dieffenbachias identified oral irritation in 2.1% (Mrvos et al, 1991) and 18.2% (Pedaci et al, 1999).
    b) Crushing, cutting, or mastication of the plant part is necessary to produce the full local reaction due to the calcium oxalate crystals (Rauber, 1985). Brief sucking on a leaf is not generally associated with toxicity.
    c) ANIMAL DATA: Studies on Dieffenbachia picta in guinea pigs demonstrated the most toxic part of the plant was the stem juice, which, when dropped into the mouths of the animals, caused lip and tongue edema, nasal secretion, and progressive respiratory difficulties (Ladeira et al, 1975).
    d) CALADIUM SPECIES: The 10 most common reported symptoms following toxic ingestions of caladium plant species, from data gathered from AAPCC TESS (i.e., Caladium bicolor) include (Mrvos et al, 2001):
    SYMPTOMPERCENT REPORTED
    Oral irritation65.9
    Throat irritation7.1
    Vomiting5.4
    Erythema2.8
    Dermal irritation2.8
    Pruritus2.4
    Nausea1.7
    Dermal edema1.8
    Oral burns1.6
    Cough0.9

    e) ALOCASIA ODORA: A 43-year-old woman bit into the root stock of an A odora plant (confirmed by an agricultural expert) while inebriated and presented 2 hours after exposure. Upon admission, she was alert and oriented with complaint of oral numbness, dyspnea and throat discomfort. She required endotracheal intubation for a swollen uvular and epiglottis; and received IV chlorpheniramine and methylprednisolone. The patient was extubated 12 hours later with mild swelling of the arytenoids and epiglottis with no respiratory complaints. However, the patient continued to complain of oral numbness and severe tongue pain and was transferred to a local hospital for further pain control and nutritional support (Moon et al, 2011).
    1) In another case, a man tasted the root of the same plant and developed oral numbness, tongue pain and nausea about 2 hours after exposure. The throat appeared slightly inflamed. Morphine was given for pain. Approximately 7 hours after presentation, the patient left against medical advice still complaining of severe tongue pain (Moon et al, 2011).
    2) SOLUBLE SALTS
    a) SUMMARY
    1) Significant poisoning by rhubarb and sorrel has been reported only after ingestion in quantity, such as when used as a food.
    b) CASE REPORTS
    1) SUMMARY: As little as half of a star fruit or approximately 25 mL of the juice can produce symptoms; however, the association between the amount ingested and symptoms is highly variable (Lee, 2012).
    2) STAR FRUIT: Following an estimated ingestion of 13.1 and 9.2 g of oxalate (in star fruit juice) in a 77- and a 38-year-old men respectively, acute oxalate nephropathy developed. Both men drank the juice on an empty stomach and both were previously healthy. After hemodialysis, both recovered (Chen et al, 2001).
    3) STAR FRUIT: A 72-year-old with dialysis dependent renal failure developed coma, hiccups, and nonconvulsive status epilepticus after ingesting half a star fruit (Chang & Yeh, 2004).
    4) STAR FRUIT: One day after ingesting 3 star fruits (about 60 g per star fruit), a 60-year-old man with diabetes mellitus, hypertension, alcoholic cirrhosis, chronic renal failure developed chills, hiccups, tremor, irritability, hearing impairment, urinary retention, acute renal failure, acute respiratory failure, coma and hypothermia (30.4 degrees C). Following 2 sessions of hemodialysis and rewarming, his body temperature returned to normal, but he remained comatose. After a 6-hour session of charcoal hemoperfusion, his consciousness returned to normal within a day (Chen et al, 2005).
    5) DIOSCOREA QUINQUELOBA: A 51-year-old healthy man ingested about 400 mL of the juice of raw tubers (D. quinqueloba) for general health and the following day he developed nausea and continuous vomiting. His wife drank a small amount of the juice and developed similar symptoms but the effects were milder and resolved a short time later. Upon admission his vital signs and laboratory studies were within normal limits. By the following day, his serum creatinine (Cr) was 2.9 mg/dL with a BUN of 42.7 mg/dL. On day 3, he was febrile (39 degrees Celsius) and developed a tonic-clonic seizure and a decreased level of consciousness. An EEG showed evidence of nonspecific and diffuse cerebral dysfunction and high anion gap metabolic acidosis was present. The patient was intubated and sedated and emergency hemodialysis was begun. By day 5, his BUN was 88.8 mg/dL and Cr was 8.6 mg/dL. He was then placed on continuous venovenous hemodiafiltration (CVVHDF) and his kidney function gradually improved. On day 12, CVVHDF was stopped and he was successfully extubated due to improved consciousness. He continued to receive supportive care and was discharged to home on day 26 with a BUN of 8.4 mg/dL and a Cr of 1.2 mg/dL (Kang & Heo, 2015).
    6) DIOSCOREA QUNQUELOBA: A 68-year-old man started taking an extract containing D. quinqueloba for about a week for diabetes mellitus. Upon admission, he was oliguric with pitting edema of his lower extremities. His initial laboratory studies revealed a serum creatinine level of 4.6 mg/dL, creatinine kinase 66 Units/L (normal range, 35 to 172), sodium 133 mEq/L, potassium of 4.7 mEq/L and a BUN of 56.6 mg/dL. Urine sodium and creatinine were 50 mEq/L and 32.2 mg/dL, respectively. Hydration therapy was initiated. His creatinine gradually declined from 5.9 to 1.2 mg/dL. By day 6, he was discharged without permanent sequelae. In the second case, the 58 year-old brother of case 1 also developed pitting edema of his lower extremities, vomiting, diarrhea and polydipsia after taking the same D. quinqueloba extract for general well being. His serum creatinine level (5.8 mg/dL) and BUN (48.2 mg/dL) were both elevated. Similarly, he was diagnosed with intrinsic acute renal failure and treated with hydration therapy. His renal function gradually improved and his creatinine level decreased to 1.3 mg/dL approximately 10 days after admission (Kim et al, 2012).

Toxicity Information

    7.7.1) TOXICITY VALUES
    A) DIEFFENBACHIA
    1) LD50- (ORAL)RAT:
    a) Greater than 160 mL/kg -- fresh expressed juice (Fochtman et al, 1969)

Toxicologic Mechanism

    A) INSOLUBLE SALTS: Many of these plants contain water-insoluble crystal needles of calcium oxalate which may cause oral irritation when ingested.
    1) Specialized cells (idioblasts) contain raphides (calcium oxalate crystals) which are injected when triggered by mechanical pressure.
    2) The combination of mechanical injury and a proteolytic enzyme that releases histamine produces an inflammatory reaction (Rauber, 1985; Gardner, 1994). The plant juices also produce an irritant dermatitis.
    B) SOLUBLE: Other plants contain soluble oxalic acid salts such as rhubarb leaves. Usually the concentration is low and pain in the mouth is minimal or absent.
    1) Nephropathy is not due so much to deposition of oxalate crystals in renal cells but is instead due to vascular stasis (Sanz & Reig, 1992). In a rat study, oxalate crystals may provoke acute renal injury by inducing apoptosis of renal epithelial cells (Lee, 2012).
    2) LUNGS: Nonspecific congestion and alveolar edema are sometimes seen in the lung (Scully et al, 1979).
    3) BRAIN: Oxalate crystals may be found in vasa walls. Focal necrosis and images of sterile meningitis with infiltrated mononuclear cells and neutrophils occur (Scully et al, 1979).

Clinical Effects

    11.1.2) BOVINE/CATTLE
    A) In ruminants, ingestion of oxalate-containing plants may cause several syndromes.
    1) Acute syndrome: Hypocalcemia and death occur soon after a large ingestion of oxalate.
    2) Subacute syndrome: Hypocalcemia and renal damage but insufficient to cause immediate death.
    3) Chronic syndrome: Nephron damage, renal fibrosis, renal insufficiency and urolithiasis secondary to calcium oxalate deposition in the renal tubules (Panciera et al, 1990).
    11.1.3) CANINE/DOG
    A) Signs of oxalate toxicity, vomiting, ataxia, and leukopenia were seen in a small dog who ingested Schefflera leaves. The oxalate content of the leaves was 0.9% to 1.5% (Stowe & Fangmann, 1975).
    B) DIEFFENBACHIA/SURVIVAL: A mature male Labrador developed a sudden onset of choking and gagging symptoms and had evidence of inspiratory stridor and abdominal tenderness upon presentation. Examination included a distended stomach and oropharyngeal swelling making tracheal intubation difficult. Following exploratory surgery, a large amount of plant matter (later identified as Dieffenbachia) was found in the stomach. A temporary tracheostomy was needed for persistent oropharyngeal swelling, but the dog was discharged on day 6 and made a complete recovery (Peterson et al, 2009).
    C) DIEFFENBACHIA/FATALITY: Death from asphyxiation occurred in a mature poodle after chewing on the thick stem of a dieffenbachia plant. The dog initially developed extensive erosive glossitis along with dyspnea that did not respond to emergency respiratory measures. Fatal asphyxiation occurred a few hours after exposure from edema of the glottis (Loretti et al, 2003).
    11.1.5) EQUINE/HORSE
    A) Horses generally die of gastroenteritis rather than kidney damage (James, 1972).
    11.1.9) OVINE/SHEEP
    A) Sheep poisoned with curly dock (Rumex crispus) displayed rapid, labored breathing, depression, ataxia and coarse tremor of the head and neck (Panciera et al, 1990).
    1) There was evidence of acute renal tubular necrosis. Calcium oxalate crystals were present in the renal tubules on histological examination (Panciera et al, 1990).
    B) Sheep poisoned with halogeton (Halogeton glomeratus) display rapid and labored respirations, depression, weakness, coma and usually death. Seizures may also occur (James, 1972).
    1) Sheep poisoned with halogeton (Halogeton glomeratus) occasionally display tetany (James, 1972).
    C) Necropsy of sheep poisoned with soursobs but not halogeton may reveal calcium oxalate crystals in the brain (James, 1972).
    11.1.10) PORCINE/SWINE
    A) Pigs poisoned by Amaranthus sp displayed weakness, ataxia, crawling movements, acute renal tubular damage, and tremor (Salles et al, 1991).
    B) Histological examination of pigs poisoned with Amaranthus sp showed evidence of acute renal tubular injury, but no oxalate crystals (Salles et al, 1991).

Treatment

    11.2.2) LIFE SUPPORT
    A) SUMMARY
    1) MAINTAIN VITAL FUNCTIONS: Secure airway, supply oxygen, and begin supportive fluid therapy if necessary.
    11.2.5) TREATMENT
    A) SHEEP
    1) Eight sheep poisoned with curly dock (Rumex crispus) were treated with oral activated charcoal, magnesium hydroxide and electrolytes and IV calcium gluconate and thiamine hydrochloride. Recumbent animals became ambulatory 6 to 8 hours following treatment (Panciera et al, 1990).

Range Of Toxicity

    11.3.2) MINIMAL TOXIC DOSE
    A) SUMMARY
    1) Oxalate poisoning in large animals occurs most commonly in plants containing more than 10% oxalic acid on a dry weight basis, which include Halogeton (Halogeton glomeratus), greasewood (Sarcobatus vermiculatus), sorrels (Oxalis spp), docks (Rumex spp) and sugar beets (Beta vulgaris).
    2) In a typical growing season, fireweed (Kochia scoparia) contained a maximum of 4.35% soluble oxalates and 11.4% total oxalates. The highest concentration of oxalates occurred from May though June. Increased oxalate concentration coincided with heavy rainfall (Dickie et al, 1989).
    3) In a case of sheep poisoned with curly dock (Rumex crispus), the plant's oxalic acid content was found to be 6.6% to 11.1% (Panciera et al, 1990).
    4) LABORATORY: In a case of 8 sheep poisoned with curly dock (Rumex crispus), pretreatment blood samples revealed azotemia (BUN 38 to 122 mg/dL), elevated creatinine (1.3 to 5.0 mg/dL) and hypocalcemia (4.2 to 8.0 mg/dL) (Panciera et al, 1990).

Continuing Care

    11.4.3) TREATMENT
    11.4.3.5) SUPPORTIVE CARE
    A) SUMMARY
    1) Ongoing treatment is symptomatic and supportive.
    11.4.3.6) OTHER
    A) OTHER
    1) SPECIFIC TOXIN
    a) HALOGETON
    1) Gross pathology of large animals poisoned with halogeton includes hemorrhage and edema of the rumen wall, ascites and hyperemia of the abomasal mucosa (James, 1972).
    2) Histopathology may include calcium oxalate crystals in the rumen wall and arterial walls of the rumen (James, 1972).
    3) In animals poisoned with halogeton (Halogeton glomeratus), serum calcium decreases while serum magnesium, phosphorus and sodium increase. Alkalosis may also be observed (James, 1972).

Sources

    A) SPECIFIC TOXIN
    1) Panciera et al (1990) report that oxalate poisoning has occurred in animals following the ingestion of halogeton (Halogeton glomeratus), soursob (Oxalis spp), pokeweed (Phytolacca americana), purslane (Portulaca oleracea), lamb's quarter (Chenopodium album), bassia (Bassia hyssopifolia), greasewood (Sarcobatus vermiculatus), pigweed (Amaranthus spp), Russian thistle (Salsola kalis), suger beets and mangels (Beta vulgaris) and rhubarb (Rheum rhaponticum).
    2) Fireweed (Kochia scoparia) has caused poisoning in grazing livestock (Dickie et al, 1989).
    3) Rumex spp have caused poisoning in both sheep and cattle (Panciera et al, 1990).
    4) Renal injury from ingestion of Amaranthus spp has occurred in pigs, cattle, sheep, goats and horses (Salles et al, 1991).
    5) Most oxalate containing plants are palatable to livestock. Sheep and cattle will graze on halogeton even when other forage is available. Under the right circumstances, large numbers of animals may be poisoned: more than 1200 sheep and 100 to 800 cattle have been poisoned at one time (James, 1972).
    6) Oxalic acid is an organic, dicarboxylic acid. The calcium and magnesium salts are insoluble. Principle soluble salts include sodium, potassium and ammonium oxalate (James, 1972).
    7) Amaranthus quitensis and Amaranthus viridis were suspected of causing acute poisoning of pigs (Salles et al, 1991).
    8) Some plants, such as soursobs and some Rumex species, have a sap pH of about 2. Therefore oxalate is present as oxalic acid. Plants, such as some Chenopodiacae, have a sap pH of about 6. Therefore, oxalate is present as the oxalate ion (James, 1972).

General Bibliography

    1) AMA Department of DrugsAMA Department of Drugs: AMA Evaluations Subscription, American Medical Association, Chicago, IL, 1992.
    2) Adhikari KM: Poisoning due to accidental ingestion of Dieffenbachia plant (Dumb cane). Indian Pediatr 2012; 49(3):247-248.
    3) Albersmeyer M, Hilge R, Schrottle A, et al: Acute kidney injury after ingestion of rhubarb: secondary oxalate nephropathy in a patient with type 1 diabetes. BMC Nephrol 2012; 13:141-141.
    4) Albihn PBE & Savage GP: The bioavailability of oxalate from OCA (Oxalis tuberosa). J Urol 2001; 166:420-422.
    5) Alessio-Alves FF, de Souza CP, da Silva LK, et al: Starfruit neurotoxicity mimicking an acute brainstem stroke. Clin Neurol Neurosurg 2012; 114(6):684-685.
    6) Archer HE, Dormer AE, & Scowen EF: Studies on the urinary excretion of oxalate by normal subjects. Clin Sci 1957; 16:405.
    7) Archer HE, Dormer AE, & Scowen EF: The aetiology of primary hyperoxaluria. Br Med J 1958; 1:175.
    8) Bottarelli F: Appunti di tossicologia: acido ossalico ed ossalati. Veterinaria 1968; 17:364-382.
    9) Brinkley L, McGuire J, & Gregory J: Bioavailability of oxalate in foods. Urology 1981; 17:534.
    10) Brophy GM, Bell R, Claassen J, et al: Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17(1):3-23.
    11) Burgess JL, Kirk M, Borron SW, et al: Emergency department hazardous materials protocol for contaminated patients. Ann Emerg Med 1999; 34(2):205-212.
    12) Causeret J: Repartition de l'acide oxalique dans les aliments. Cah Nutr Diet 1985; 2:345-352.
    13) Chamberlain JM, Altieri MA, & Futterman C: A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Ped Emerg Care 1997; 13:92-94.
    14) Chan CK, Li R, Shum HP, et al: Star fruit intoxication successfully treated by charcoal haemoperfusion and intensive haemofiltration. Hong Kong Med J 2009; 15(2):149-152.
    15) Chan TYK, Chan LY, & Tam LS: Neurotoxicity following the ingestion of a Chinese medicinal plant, Alocasia macrorrhiza. Human Experiment Toxicol 1995; 14:727-728.
    16) Chang CH & Yeh JH: Non-convulsive status epilepticus and consciousness disturbance after star fruit (Averrhoa carambola) ingestion in a dialysis patient. Nephrology 2004; 9:362-365.
    17) Chang CT, Chen YC, & Fang JT: Star fruit (Averrhoa carambola) intoxication: an important cause of consciousness disturbance in patients with renal failure. Renal Fail 2002; 24:379-382.
    18) Chang JM, Hwang SJ, & Kuo HT: Fatal outcome after ingestion of star fruit (Averrhoa carambola) in uremic patients. Am J Kidney Dis 2000; 35:189-193.
    19) Chen CL, Fang HC, & Chou KJ: Acute oxalate nephropathy after ingestion of star fruit. Am J Kidney Dis 2001; 37:418-422.
    20) Chen LL, Fang JT, & LL J: Chronic renal disease patients with severe star fruit poisoning: hemperfusion may be an effective alternative therapy. Clin Toxicol 2005; 43:197-199.
    21) Chen SH , Tsai MH , Tseng YL , et al: Star fruit intoxication in a patient with moderate renal insufficiency presents as a posterior reversible encephalopathy syndrome. Acta Neurol Taiwan 2010; 19(4):287-291.
    22) Chin RF , Neville BG , Peckham C , et al: Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study. Lancet Neurol 2008; 7(8):696-703.
    23) Choonara IA & Rane A: Therapeutic drug monitoring of anticonvulsants state of the art. Clin Pharmacokinet 1990; 18:318-328.
    24) Cumpston KL, Vogel SN, Leikin JB, et al: Acute airway compromise after brief exposure to a Dieffenbachia plant. J Emerg Med 2003; 25(4):391-397.
    25) Dickie CW, Gerlach ML, & Hamar DW: Kochia scoparia oxalate content. Vet Hum Toxicol 1989; 31:240-242.
    26) Drach G & Maloney WH: Toxicity of the common houseplant Dieffenbachia. JAMA 1963; 184:1047-1048.
    27) Earnest DL, Williams HE, & Admirand WH: A physico-chemical basis for treatment of enteric hyperoxaluria. Trans Assoc Am Phys 1975; 88:224.
    28) Fang HC, Chen CL, & Wang JS: Acute oxalate nephropathy induced by star fruit in rats. Am J Kidney Dis 2001; 38:876-880.
    29) Faragalla FF & Gershoff SN: Occurrence of C(14)-oxalate in rat urine after administration of C(14)-tryptophan. Proc Soc Exp Biol Med 1963; 114:602.
    30) Farre M, Xirgu J, & Salgado A: Fatal oxalic acid poisoning from sorrel soup. Lancet 1989; 2:1524.
    31) Finch AM, Kasidas GP, & Rose GA: Urine composition in normal subjects after oral ingestion of oxalate-rich foods. Clin Sci 1981; 60:411.
    32) Franceschi VR & Horner HT: Calcium oxalate crystals in plants. Bot Rev 1980; 46:361-427.
    33) Gardner DG: Injury to the oral mucous membranes caused by the common houseplant. Oral Surg Oral Med Oral Pathol 1994; 78:631-633.
    34) Gosselin RE, Smith RP, & Hodge HC: Clinical Toxicology of Commercial Products, 5th ed, Williams & Wilkins, Baltimore, MD, 1984.
    35) Hanson CF, Frankos VH, & Thompson WO: Bioavailability of oxalic acid from spinach, sugar beet fibre and a solution of sodium oxalate consumed by female volunteers. Fd Chem Toxicol 1989; 27:181-184.
    36) Hegenbarth MA & American Academy of Pediatrics Committee on Drugs: Preparing for pediatric emergencies: drugs to consider. Pediatrics 2008; 121(2):433-443.
    37) Hvidberg EF & Dam M: Clinical pharmacokinetics of anticonvulsants. Clin Pharmacokinet 1976; 1:161.
    38) James LF: Oxalate toxicosis. Clin Toxicol 1972; 5:231-243.
    39) Kalliala H & Kauste O: Ingestion of rhubarb as cause of oxalic acid poisoning. Ann Paediatr Fenn 1964; 10:228-231.
    40) Kang KS & Heo ST: A case of life-threatening acute kidney injury with toxic encephalopathy caused by Dioscorea quinqueloba. Yonsei Med J 2015; 56(1):304-306.
    41) Kasilo OJ: Epidemiology and management of poisoning due to natural toxins from mushrooms, elephant's ear and traditional medicine (muti). Bull Dept Pharmacy-Drug and Toxicol Info Service. University of Zimbabwe 1990; 21:5.
    42) Kim CS, Kim SM, Choi JS, et al: Dioscorea quinqueloba induces acute kidney injury. Clin Toxicol (Phila) 2012; 50(1):80.
    43) Krenzelok EP, Jacobsen TD, & Aronis JM: A review of 96,659 dieffenbachia and philodendron exposures (abstract). J Toxicol - Clin Toxicol 1996; 34:601.
    44) Lee KG: Star fruit intoxication with acute kidney injury. Clin Med 2012; 12(5):494-494.
    45) Lieberman P, Nicklas R, Randolph C, et al: Anaphylaxis-a practice parameter update 2015. Ann Allergy Asthma Immunol 2015; 115(5):341-384.
    46) Lieberman P, Nicklas RA, Oppenheimer J, et al: The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126(3):477-480.
    47) Lin TJ, Hung DZ, & Hu WH: Calcium oxalate is the main toxic component in clinical presentations of Alocasis macrorrhiza (L) Schott and Endl poisonings. Vet Human Toxicol 1998; 40:93-95.
    48) Loddenkemper T & Goodkin HP: Treatment of Pediatric Status Epilepticus. Curr Treat Options Neurol 2011; Epub:Epub.
    49) Loretti AP, da Silva Ilha MR, & Ribeiro RE: Accidental fatal poisoning of a dog by Dieffenbachia picta (dumb cane). Vet Hum Toxicol 2003; 45(5):233-239.
    50) Manno EM: New management strategies in the treatment of status epilepticus. Mayo Clin Proc 2003; 78(4):508-518.
    51) McIntire MS, Guest, & Porterfield JF: Philodendron - an infant death. J Toxicol Clin Toxicol 1990; 28:177-183.
    52) Mihailidou H, Galanakis E, Paspalaki P, et al: Pica and the Elephant's ear. J Child Neurol 2002; 17:855-856.
    53) Moon JM, Lee BK, & Chun BJ: Toxicities of raw Alocasia odora. Hum Exp Toxicol 2011; 30(10):1720-1723.
    54) Morton JF: Plants poisonous to people in Florida and other warm areas, Hurricane House, Miami, FL, 1971.
    55) Mrvos R, Dean BS, & Krenzelok EP: Philodendron/dieffenbachia ingestions: are they a problem?. Clin Toxicol 1991; 29:485-491.
    56) Mrvos R, Krenzelok EP, & Jacobsen TD: Toxidromes associated with the most common plant ingestions. Vet Human Toxicol 2001; 43:366-369.
    57) Naradzay J & Barish RA: Approach to ophthalmologic emergencies. Med Clin North Am 2006; 90(2):305-328.
    58) National Heart,Lung,and Blood Institute: Expert panel report 3: guidelines for the diagnosis and management of asthma. National Heart,Lung,and Blood Institute. Bethesda, MD. 2007. Available from URL: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
    59) Nelson LS, Shih RD, & Balick MJ: Handbook of Poisonous and Injurious Plants, 2nd ed. Springer, New York, NY, 2007, pp -.
    60) Neto MM, Robl F, & Netto JC: Intoxication by star fruit (Averrhoe carambola) in six dialysis patients? (Preliminary report). Nephrol Dial Transplant 1998; 13:570-572.
    61) Nowak RM & Macias CG : Anaphylaxis on the other front line: perspectives from the emergency department. Am J Med 2014; 127(1 Suppl):S34-S44.
    62) Panciera RJ, Martin T, & Burrows GE: Acute oxalate poisoning attributable to ingestion of curly dock (Rumex crispus) in sheep. J Am Vet Med Assoc 1990; 196:1981-1984.
    63) Peate WF: Work-related eye injuries and illnesses. Am Fam Physician 2007; 75(7):1017-1022.
    64) Pedaci L, Krenzelok EP, & Jacobsen TD: Dieffenbachia species exposures: an evidence-based assessment of symptom presentation. Vet Hum Toxicol 1999 (in press); 41(5):335-338.
    65) Petersen DD: Common plant toxicology: a comparison of national and southwest Ohio data trends on plant poisonings in the 21st century. Toxicol Appl Pharmacol 2011; 254(2):148-153.
    66) Peterson K, Beymer J, Rudloff E, et al: Airway obstruction in a dog after Dieffenbachia ingestion. J Vet Emerg Crit Care (San Antonio) 2009; 19(6):635-639.
    67) Product Information: diazepam IM, IV injection, diazepam IM, IV injection. Hospira, Inc (per Manufacturer), Lake Forest, IL, 2008.
    68) Product Information: diphenhydramine HCl intravenous injection solution, intramuscular injection solution, diphenhydramine HCl intravenous injection solution, intramuscular injection solution. Hospira, Inc. (per DailyMed), Lake Forest, IL, 2013.
    69) Product Information: lorazepam IM, IV injection, lorazepam IM, IV injection. Akorn, Inc, Lake Forest, IL, 2008.
    70) Rauber A: Observations on the idioblasts of Dieffenbachia. Clin Toxicol 1985; 23:79-90.
    71) Reig R, Sanz P, & Blanche C: Fatal poisoning by Rumex crispus (curled dock): pathological findings and application of scanning electron microscopy. Vet Hum Toxicol 1990; 32:468.
    72) Salles MS, Lombardo de Barros CS, & Lemos RA: Perirenal edema associated with Amaranthus Spp poisoning in Brazilian swine. Vet Hum Toxicol 1991; 33:616-617.
    73) Sanz P & Reig R: Clinical and pathological findings in plant oxalosis. A review. Am J Forensic Med Pathol 1992; 13:342-345.
    74) Scott R, Besag FMC, & Neville BGR: Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomized trial. Lancet 1999; 353:623-626.
    75) Scully RE, Galdabini JJ, & McNeely BU: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercise. Case 38-1979. New Engl J Med 1979; 301:650-657.
    76) Selcuk SN, Gulhan B, Duzova A, et al: Acute tubulointerstitial nephritis due to large amount of sorrel (Rumex acetosa) intake. Clin Toxicol (Phila) 2015; 53(5):497.
    77) Singh PP: Cardiovascular effects and toxicity of oxalic acid and oxalates. Asian Med J 1973; 16:21.
    78) Sreenath TG, Gupta P, Sharma KK, et al: Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: A randomized controlled trial. Eur J Paediatr Neurol 2009; Epub:Epub.
    79) Stowe CM & Fangmann G: Schefflera toxicosis in a dog. JAVMA 1975; 167:74.
    80) Streicher E: Acutes Nierenversagen und Ikterus nach einer Vergiftung mit Rhabarberblattern. Dtsch Med Wochenschr 1964; 89:2379-2381.
    81) Tagwireyi D & Ball DE: The management of elephant's ear poisoning. Hum Exper Toxicol 2001; 20:189-192.
    82) Tallqvist H & Vaananen T: Death of a child from oxalic acid poisoning due to eating rhubarb leaves. Ann Pediatr Fenn 1960; 6:144-147.
    83) Tsai M, Chang W, Lui C, et al: Status epilepticus induced by star fruit intoxication in patients with chronic renal disease. Seizure 2005; 14(7):521-525.
    84) Tse KC, Yip PS, Lam MF, et al: Star fruit intoxication in uraemic patients: case series and review of the literature. Intern Med J 2003; 33(7):314-316.
    85) Vanden Hoek,TL; Morrison LJ; Shuster M; et al: Part 12: Cardiac Arrest in Special Situations 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. American Heart Association. Dallas, TX. 2010. Available from URL: http://circ.ahajournals.org/cgi/reprint/122/18_suppl_3/S829. As accessed 2010-10-21.
    86) Vicary P: Haematuria. BMJ 1977; 2:642.
    87) Watson JT, Jones RC, Siston AM, et al: Outbreak of food-borne illness associated with plant material containing raphides. Clin Toxicol 2005; 1:17-21.
    88) Wu CL, Chiu PF, Yang Y, et al: Sustained low-efficiency daily diafiltration with hemoperfusion as a therapy for severe star fruit intoxication: a report of two cases. Ren Fail 2011; 33(8):837-841.
    89) Wu MY, Wu IW, Wu SS, et al: Hemoperfusion as an effective alternative therapy for star fruit intoxication: a report of 2 cases. Am J Kidney Dis 2007; 49(1):e1-e5.
    90) Yap HJ, Chen YC, & Fang JT: Star fruit: a neglected but serious fruit intoxicant in chronic renal failure. Dialysis Transplant 2002; 31:564-567.